Ajanta Pharma

{
  "main_header": {
    "sid": 178818,
    "name": "Ajanta Pharma",
    "stock_name": "Ajanta Pharma",
    "full_name": "Ajanta Pharma Ltd.",
    "name_url": "stocks-analysis/ajanta-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "3,480.20",
    "chg": 8.2,
    "chgp": "0.24%",
    "dir": 1,
    "prev_price": "3,472.00",
    "mcapval": "43,488.24 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532331,
    "symbol": "AJANTPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE031B01049",
    "curr_date": "Aug 07, 03:32 PM",
    "curr_time": "15:34 PM",
    "last_traded_at": "Aug 07, 03:32 PM IST",
    "bse_nse_vol": "37.85 k",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ajanta-pharma-178818-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MS",
      "url": "https://www.marketsmojo.com/mojostocks#!#top10",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ajanta-pharma-178818-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Ajanta Pharma Ltd. is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajanta-pharma-ltd-is-rated-buy-4133453",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AjantaPharmaLtd_mojoScore_4133453.png",
        "date": "2026-08-03 10:11:08",
        "description": "Ajanta Pharma Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 03 August 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Ajanta Pharma Gains 3.08%: 2 Key Factors Driving the Weekly Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-gains-308-2-key-factors-driving-the-weekly-rally-4132517",
        "imagepath": "",
        "date": "2026-08-02 14:01:14",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Stock opens at Rs.3,383.95, Sensex up 1.05%</p>\n                    <p><strong>28 Jul:</strong> Stock dips 1.42% amid broader market weakness</p>\n                    <p><strong>29 Jul:</strong> Strong rebound with 1.85% gain following positive sentiment</p>\n                    <p><strong>30 Jul:</strong> Ajanta Pharma reports stellar Q1 FY27 results, stock rises 0.93%</p>\n                    <p><strong>31 Jul:</strong> Financial outlook upgraded, stock closes at Rs.3,470.10 (+1.19%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.3,366.4..."
      },
      {
        "title": "Has Ajanta Pharma Ltd. declared dividend?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/has-ajanta-pharma-ltd-declared-dividend-4130888",
        "imagepath": "",
        "date": "2026-07-31 23:31:55",
        "description": "Ajanta Pharma Ltd. has declared a dividend.\n\nDividend Details:\n- Percentage announced: 1600%\n- Amount per share: ₹28.04\n- Ex-date: 05 Aug 26\n\nDividend Yield: 0.82%\n\nTotal Returns by Period:\nIn the 3-month period, Ajanta Pharma Ltd. achieved a price return of 22.85%, a dividend return of 1.10%, resulting in a total return of 23.95%.\n\nFor the 6-month period, the company reported a price return of 24.65%, a dividend return of 1.14%, leading to a total return of 25.79%.\n\nOver the 1-year period, the price return was 26.65%, with a dividend return of 2.28%, culminating in a total return of 28.93%.\n\nIn the 2-year period, Ajanta Pharma Ltd. experienced a price return of 29.0%, a dividend return of 2.87%, which resulted in a total return of 31.87%.\n\nFor the 3-year period, the company saw a significant price return of 104.52%, with a dividend return of 6.44%, achieving a total return of 110.96%.\n\nIn the 4-year period..."
      },
      {
        "title": "Are Ajanta Pharma Ltd. latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-ajanta-pharma-ltd-latest-results-good-or-bad-4130615",
        "imagepath": "",
        "date": "2026-07-31 19:18:53",
        "description": "Ajanta Pharma Ltd. has reported strong financial results for the quarter ended June 2026, showcasing significant growth in both net sales and net profit. The company achieved net sales of ₹1,625.96 crores, reflecting a year-on-year growth of 24.82%, which is a notable improvement compared to the previous year's growth of 13.78%. This performance marks the highest quarterly revenue in the company's history, driven by robust demand across its branded generics portfolio in various markets, including India, Asia, and Africa.\n\nNet profit for the same quarter reached ₹334.22 crores, representing a year-on-year increase of 30.89%, a substantial rise from the 3.89% growth seen in the previous year. This growth in profitability underscores the company's ability to effectively convert revenue growth into bottom-line results.\n\nHowever, the operating margin (excluding other income) contracted slightly to 26.05%, down f..."
      },
      {
        "title": "Ajanta Pharma Ltd. Reports Strong Quarterly Growth, Upgrades Financial Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-ltd-reports-strong-quarterly-growth-upgrades-financial-outlook-4129346",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AjantaPharmaLtd_fintrenddot_4129346.png",
        "date": "2026-07-31 08:00:05",
        "description": "Ajanta Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a marked improvement in its financial performance for the quarter ended June 2026. The company’s recent upgrade from Hold to Buy by MarketsMOJO reflects its robust revenue growth, margin expansion, and positive financial trend reversal, signalling renewed investor confidence amid a challenging market backdrop."
      },
      {
        "title": "Ajanta Pharma Q1 FY27: Stellar Quarter Drives 31% Profit Surge",
        "link": "https://www.marketsmojo.com/news/result-analysis/ajanta-pharma-q1-fy27-stellar-quarter-drives-31-profit-surge-4129136",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AjantaPharma_quaterlyResult_4129136.png",
        "date": "2026-07-30 20:00:35",
        "description": "Ajanta Pharma Ltd., a mid-cap specialty pharmaceutical formulation company with a market capitalisation of ₹42,566 crores, reported a robust performance for Q1 FY27, with consolidated net profit surging 30.89% year-on-year to ₹334.22 crores from ₹255.34 crores in Q1 FY26. On a sequential basis, the company posted an even stronger 25.32% quarter-on-quarter growth from ₹266.70 crores in Q4 FY26, marking the highest quarterly profit in the company's recent history."
      },
      {
        "title": "Ajanta Pharma Ltd Gains 1.53% Early Week Before Profit-Taking Pullback: 4 Key Factors Driving the Move",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-ltd-gains-153-early-week-before-profit-taking-pullback-4-key-factors-driving-the-move-4121480",
        "imagepath": "",
        "date": "2026-07-26 16:02:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Jul:</strong> Stock opens week at Rs.3,469.20 with a 1.53% gain</p>\n                    <p><strong>21 Jul:</strong> New 52-week high and all-time high reached at Rs.3,598.4</p>\n                    <p><strong>22 Jul:</strong> Profit-taking leads to 3.31% decline after hitting new high</p>\n                    <p><strong>24 Jul:</strong> Week closes at Rs.3,366.45, down 0.31% from previous close</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.3,416.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div clas..."
      },
      {
        "title": "Ajanta Pharma Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajanta-pharma-ltd-is-rated-hold-by-marketsmojo-4117545",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AjantaPharmaLtd_mojoScore_4117545.png",
        "date": "2026-07-23 10:11:14",
        "description": "Ajanta Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 July 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Ajanta Pharma Ltd. to 52-Week High of Rs 3598.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-ltd-hits-new-52-week-high-at-rs35984-4114805",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AjantaPharmaLtd_priceRelatedfactors_4114805.png",
        "date": "2026-07-22 09:43:35",
        "description": "From a 52-week low of Rs 2,335 to a fresh peak of Rs 3,598.4 on 22 Jul 2026, Ajanta Pharma Ltd. has delivered a robust 26.8% gain over the past year, outpacing the Sensex’s decline of 6.4%. This milestone reflects a sustained uptrend fuelled by a confluence of bullish technical indicators and steady price momentum."
      }
    ],
    "total": 675,
    "sid": "178818",
    "stock_news_url": "https://www.marketsmojo.com/news/ajanta-pharma-178818"
  },
  "announcements": [
    {
      "caption": "Participation In Investor Conference",
      "datetime": "05-Aug-2026",
      "details": "Pls find enclosed Intimation w.r.t participation in Investor Conference",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "03-Aug-2026",
      "details": "Pls find enclosed herewith Earning Call Transcript",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "31-Jul-2026",
      "details": "Pls find enclosed newspaper publication of financial results for the quarter ended 30.06.2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has declared <strong>1600%</strong> dividend, ex-date: 05 Aug 26",
          "dt": "2026-08-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has announced <strong>2:5</strong> stock split, ex-date: 20 Mar 15",
          "dt": "2015-03-20",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has announced <strong>1:2</strong> bonus issue, ex-date: 22 Jun 22",
          "dt": "2022-06-22",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Ajanta Pharma Ltd. is Rated Buy

2026-08-03 10:11:08

Ajanta Pharma Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 03 August 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, returns, and overall outlook.

Read full news article

Ajanta Pharma Gains 3.08%: 2 Key Factors Driving the Weekly Rally

2026-08-02 14:01:14

Key Events This Week

27 Jul: Stock opens at Rs.3,383.95, Sensex up 1.05%

28 Jul: Stock dips 1.42% amid broader market weakness

29 Jul: Strong rebound with 1.85% gain following positive sentiment

30 Jul: Ajanta Pharma reports stellar Q1 FY27 results, stock rises 0.93%

31 Jul: Financial outlook upgraded, stock closes at Rs.3,470.10 (+1.19%)

Week Open

Rs.3,366.4...

Read full news article

Has Ajanta Pharma Ltd. declared dividend?

2026-07-31 23:31:55

Ajanta Pharma Ltd. has declared a dividend. Dividend Details: - Percentage announced: 1600% - Amount per share: ₹28.04 - Ex-date: 05 Aug 26 Dividend Yield: 0.82% Total Returns by Period: In the 3-month period, Ajanta Pharma Ltd. achieved a price return of 22.85%, a dividend return of 1.10%, resulting in a total return of 23.95%. For the 6-month period, the company reported a price return of 24.65%, a dividend return of 1.14%, leading to a total return of 25.79%. Over the 1-year period, the price return was 26.65%, with a dividend return of 2.28%, culminating in a total return of 28.93%. In the 2-year period, Ajanta Pharma Ltd. experienced a price return of 29.0%, a dividend return of 2.87%, which resulted in a total return of 31.87%. For the 3-year period, the company saw a significant price return of 104.52%, with a dividend return of 6.44%, achieving a total return of 110.96%. In the 4-year period...

Read full news article

Are Ajanta Pharma Ltd. latest results good or bad?

2026-07-31 19:18:53

Ajanta Pharma Ltd. has reported strong financial results for the quarter ended June 2026, showcasing significant growth in both net sales and net profit. The company achieved net sales of ₹1,625.96 crores, reflecting a year-on-year growth of 24.82%, which is a notable improvement compared to the previous year's growth of 13.78%. This performance marks the highest quarterly revenue in the company's history, driven by robust demand across its branded generics portfolio in various markets, including India, Asia, and Africa. Net profit for the same quarter reached ₹334.22 crores, representing a year-on-year increase of 30.89%, a substantial rise from the 3.89% growth seen in the previous year. This growth in profitability underscores the company's ability to effectively convert revenue growth into bottom-line results. However, the operating margin (excluding other income) contracted slightly to 26.05%, down f...

Read full news article

Ajanta Pharma Ltd. Reports Strong Quarterly Growth, Upgrades Financial Outlook

2026-07-31 08:00:05

Ajanta Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a marked improvement in its financial performance for the quarter ended June 2026. The company’s recent upgrade from Hold to Buy by MarketsMOJO reflects its robust revenue growth, margin expansion, and positive financial trend reversal, signalling renewed investor confidence amid a challenging market backdrop.

Read full news article

Ajanta Pharma Q1 FY27: Stellar Quarter Drives 31% Profit Surge

2026-07-30 20:00:35

Ajanta Pharma Ltd., a mid-cap specialty pharmaceutical formulation company with a market capitalisation of ₹42,566 crores, reported a robust performance for Q1 FY27, with consolidated net profit surging 30.89% year-on-year to ₹334.22 crores from ₹255.34 crores in Q1 FY26. On a sequential basis, the company posted an even stronger 25.32% quarter-on-quarter growth from ₹266.70 crores in Q4 FY26, marking the highest quarterly profit in the company's recent history.

Read full news article

Ajanta Pharma Ltd Gains 1.53% Early Week Before Profit-Taking Pullback: 4 Key Factors Driving the Move

2026-07-26 16:02:06

Key Events This Week

20 Jul: Stock opens week at Rs.3,469.20 with a 1.53% gain

21 Jul: New 52-week high and all-time high reached at Rs.3,598.4

22 Jul: Profit-taking leads to 3.31% decline after hitting new high

24 Jul: Week closes at Rs.3,366.45, down 0.31% from previous close

Week Open

Rs.3,416.80

Week Close

Read full news article

Ajanta Pharma Ltd. is Rated Hold by MarketsMOJO

2026-07-23 10:11:14

Ajanta Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Broad-Based Technical Strength Lifts Ajanta Pharma Ltd. to 52-Week High of Rs 3598.4

2026-07-22 09:43:35

From a 52-week low of Rs 2,335 to a fresh peak of Rs 3,598.4 on 22 Jul 2026, Ajanta Pharma Ltd. has delivered a robust 26.8% gain over the past year, outpacing the Sensex’s decline of 6.4%. This milestone reflects a sustained uptrend fuelled by a confluence of bullish technical indicators and steady price momentum.

Read full news article

View All News